InspireMD (NSPR) EBIT Margin (2010 - 2025)

InspireMD's (NSPR) quarterly EBIT Margin came in at 383.74% in Q4 2025, up 9686.0% year-on-year from 3.92% in Q4 2024, and up 25.82% quarter-over-quarter from 517.28% in Q3 2025.

InspireMD (NSPR) EBIT Margin (2010 - 2025) Analysis & Trends

InspireMD's EBIT Margin history runs 16 years deep, the most recent figure standing at 383.74% for Q4 2025.

  • On a quarterly basis, EBIT Margin rose 9686.0% year-over-year to 383.74% in Q4 2025; TTM through Dec 2025 was 552.56%, a 7456.0% decrease from a year earlier, with the FY2025 full-year figure at 552.56%, down 7456.0% from the prior year.
  • EBIT Margin advanced to 383.74% in Q4 2025 per NSPR's latest filing, from 517.28% in the prior quarter.
  • Across five years, EBIT Margin topped out at 284.86% in Q4 2021 and bottomed at 749.51% in Q1 2025.
  • The 5-year median for EBIT Margin is 377.79% (2021), against an average of 423.75%.
  • Across the five-year window, EBIT Margin surged 206831 bps in 2021 and tumbled 25884 bps in 2025, its largest moves.
  • Year by year, EBIT Margin stood at 284.86% in 2021, then tumbled by 69 bps to 481.09% in 2022, then soared by 31 bps to 329.81% in 2023, then sank by 46 bps to 480.61% in 2024, then climbed by 20 bps to 383.74% in 2025.
  • Per Business Quant, the three latest NSPR EBIT Margin figures stand at 383.74% (Q4 2025), 517.28% (Q3 2025), and 732.23% (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Abbott Laboratories 182.52 Bn 175.22 Bn 6.27 Bn 12.05%
2 Stryker 128.96 Bn 126.09 Bn 3.81 Bn 15.55%
3 Medtronic 107.99 Bn 98.77 Bn 6.41 Bn 19.10%
4 Boston Scientific 67.76 Bn 66.31 Bn 3.61 Bn 21.16%
5 Edwards Lifesciences 48.09 Bn 44.41 Bn 1.29 Bn 28.97%
6 Dexcom 28.30 Bn 27.18 Bn 750.30 Mn 21.42%
7 GE HealthCare Technologies 27.89 Bn 25.61 Bn 1.98 Bn 10.04%
8 Smith & Nephew 27.02 Bn 26.45 Bn - -
9 Koninklijke Philips 23.98 Bn 20.86 Bn 2.07 Bn 6.17%
10 InspireMD 43.74 Mn -10.47 Mn 1.18 Mn -383.74%

Historic Data

Download Data
DateValue
Dec 31, 2025 -383.74%
Sep 30, 2025 -517.28%
Jun 30, 2025 -732.23%
Mar 31, 2025 -749.51%
Dec 31, 2024 -480.61%
Sep 30, 2024 -467.51%
Jun 30, 2024 -474.99%
Mar 31, 2024 -490.67%
Dec 31, 2023 -329.81%
Sep 30, 2023 -362.40%
Jun 30, 2023 -322.32%
Mar 31, 2023 -353.59%
Dec 31, 2022 -481.09%
Sep 30, 2022 -322.15%
Jun 30, 2022 -305.75%
Mar 31, 2022 -379.21%
Dec 31, 2021 -284.86%
Sep 30, 2021 -376.38%
Jun 30, 2021 -331.41%
Mar 31, 2021 -329.42%